Press release
Combination Antibody Therapy Market : Lung cancer to Rise at a CAGR of 17% CAGR by 2024
Higher success ratio in treating and preventing cancer cells using combination antibody therapy is fuelling the demand for combination antibody drugs in the market. A study conducted by Persistence Market Research (PMR) shows that the global market for combination antibody therapy is set to ride on a value CAGR of over 14% during the period of assessment to reach US$ 144,734.5 Million by 2024 end. In 2016, the global market was valued at over US$ 49,994 Million characterizing the overwhelming popularity of antibody/antibody drugs amongst both practitioners and patients observed in recent years.
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/11740
Combination antibody therapy is receiving higher recognition from the oncological branch of medical science research. This is primarily due to the growing use of combination therapy over single drug treatments such as radiation or chemotherapy. In addition, companies that manufacture combination antibody drugs are actively focusing on developing superior drugs that will deliver standout results. Factors such as encouraging government policies, growing concerns over higher cancer prevalence worldwide, and increasing research and development activities coupled with heavier investments are expected to boost the overall market growth in the near future. Likewise, healthy R&D pipelines are leading towards higher product offerings and also propelling the growth of global combination antibody therapy market to a significant extent.
The prolonged attrition rate in product development cycle and arbitrary and stringent drug approval procedures are the major downsides of the market that are likely to inhibit the market growth during the forecast period. Moreover, lack of awareness on understanding the difference between immunotherapies and chemotherapies amongst healthcare professionals, which is restricting the optimal use of immunotherapies alongside conventional treatment modalities is an additional factor impeding the market growth. Further, late diagnosis or ignorance of any carcinogenic disorders may inevitably lead to higher cost of treatment.
Browse Complete Report @ https://www.persistencemarketresearch.com/market-research/combination-antibody-therapy-market.asp
Based on combinations, antibody/antibody is projected to be the predominant segment of the market over the forecast period. In terms of revenue, the segment is expected to witness a healthy CAGR of over 17% between 2016 and 2024. The growth is attributed to the increasing preference of antibody/antibody drugs as they have a lower risk of side effects for various cancer therapies. Whereas, the chemotherapy/antibody segment will hold the second position, accounting for 38.3% share of the market in 2016.
By end user, hospitals are expected to be the largest segment of the market throughout the forecast period. In 2015, the segment was valued at US$ 26,906.5 Million, which is expected to surpass US$ 95,885 Million by 2024 end, reflecting a CAGR of 15.2%.
Request to view table of content @ https://www.persistencemarketresearch.com/market-research/combination-antibody-therapy-market/toc
From a regional perspective, North America will continue to be the leading market for combination antibody therapy over the forecast period. In addition, the region is set to witness a CAGR of over 13% in terms of value. Whereas, APAC is expected to reflect the fastest growth of the market during the forecast period in terms of value. Further, the market in the region is estimated to witness a 3.4X growth in terms of sales over 2024 owing to increasing prevalence of carcinogenic disorders in APAC.
Key participants functioning in the global market for combination antibody therapy include Roche Holdings AG, Amgen Incorporated, Novartis AG, Celgene Corporation, Biogen Inc., Seattle Genetics Inc., Genmab A/S, Bristol-Myers Squibb Company, Eli-Lilliy and Company and Sanofi.
Global Market Study on Combination Antibody Therapy is available for US$4,900 https://www.persistencemarketresearch.com/checkout/11740
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Combination Antibody Therapy Market : Lung cancer to Rise at a CAGR of 17% CAGR by 2024 here
News-ID: 691090 • Views: …
More Releases from Persistence Market Research Pvt. Ltd
Innovative Rehabilitation Technologies Drive Growth in Stroke Rehabilitation Mar …
Stroke Rehabilitation Market Size
The global stroke rehabilitation market size was valued at US$ 266.4 million in 2021 and is expected to grow at a CAGR of 9% from 2022 to 2032. Revenue generated from the sales of stroke rehabilitation solutions will surge to US$ 679.6 Million by the end of 2032.
The growth of the market is being driven by the increasing incidence of strokes, the growing demand for innovative rehabilitation…
Launch of New Laser-Based Devices by Key Players Fueling Growth of Global Aesthe …
Market Study on Aesthetic Lasers
The aesthetic lasers market reached US$2.8 billion in global revenue in 2021, and it will continue to expand quickly, with a value CAGR of 6.4%, to reach US$5.5 billion by the end of 2032. The growth of the market is being driven by the increasing demand for minimally invasive cosmetic procedures, rising disposable income, technological advancements, and growing medical tourism.
Stay Ahead with Market Intelligence Get Free…
Predictive Insights for Precision Medicine: The Global Biosimulation Market is S …
Biosimulation Market Research
The Global Biosimulation Market Size was valued at USD 2.9 billion in 2022 and is expected to reach USD 10.0 billion by 2030, registering a CAGR of 16.9% during the forecast period. The growth of the biosimulation market is being driven by the increasing use of biosimulation in a variety of applications, such as drug discovery, clinical trials, and toxicity prediction.
Market Overview
The biosimulation market has experienced rapid growth…
Wheelchair and Components Market: Growing Demand for Lightweight and Smart Wheel …
Wheelchair and Components Market
The global wheelchair and components market is projected to reach USD 17.9 billion by 2033, at a CAGR of 3.7% from 2022-2033. The growth of the market is driven by the increasing prevalence of disabilities, the rising geriatric population, and technological advancements in wheelchair design and manufacturing.
Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12961
The global wheelchair and components market has witnessed significant growth in…
More Releases for CAGR
Cat Litter Box Market | CAGR of 9.1% | Revenue & CAGR of 9.1%
Cat Litter Box Market Report provides precise data about the market size, commercialization aspects and revenue forecast of the industry. The global Cat Litter Box market offers a historical factsheet relevant to the strategic mergers, acquirements, joint venture activities, and partnerships spread in the Cat Litter Box market. The most advanced data has been presented in the study on the revenue numbers, product details, and sales of the major firms.…
Predictive Analytics Market Growing at Strong CAGR of CAGR of 25.31% 2019
Predictive analytics helps to extract information from the existing data. It helps in understanding the pattern and predict the trend or future for the organization. It uses what-if scenarios to predict possible risks involved in the future. Predictive analytics also helps in the optimization of the marketing campaigns and understanding of the customer behaviour for increasing the end-user response and to reduce the churn.
Predictive analytics is segmented into:
Risk management:…
Global Absorption Chillers Market Reflecting a CAGR of 7.6% CAGR through 2025
The demand for thermally-driven chillers in multiple industrial verticals is poised to grow in the immediate future. Considering the rising demand for electrical chillers in commercial, residential as well as industrial settings, the adoption of absorption chillers will gain traction at considerable rate. By consuming lesser energy than conventional electrical chillers, absorption chillers will also garner surplus demand for not using ozone-depleting chlorofluorocarbons (CFC) for chilling purposes. Persistence Market Research’s…
Aircraft Sensors Market Growing at a CAGR of 6.4% CAGR By 2022
The global aircraft sensors market is forecasted to receive a strong push in its growth momentum on the back of advancements in technologies, massive investments forwarded by private equity groups, and the elevation in the demand for aircraft. Adherence to the requirements and regulations of authorities such as local aircraft regulatory bodies and the Federal Aviation Administration (FAA) could pamper the growth of the market. Nonetheless, there could be more…
China Baby Diapers Market Reflecting a CAGR of 19.1% CAGR 2012-2017
The increasing birth rate in China has proven to be a boon for the country’s baby diaper’s market. To provide a comprehensive analysis of the growth trajectory exhibited by the China baby diapers market and study the impact of the dynamic regulatory policies on the market, Transparency Market Research (TMR) has published a report, titled “Baby Diapers Market - China Industry Analysis, Market Size, Share, Growth, Trends And Forecast, 2012…
Ecg Device Market Register a CAGR Growth of 4.1% CAGR by 2024
This region holds highest market share over the forecast period (2016-2024) and is expected to exhibit slow growth rate. The Asia Pacific is expected to be the fastest-growing region for ECG devices owing to its increasing incidence rate of cardiovascular diseases and high population.
ECG devices are experiencing a paradigm technological shift from resting ECG systems to portable Holter monitoring systems, owing to their advantages of patient mobility, low prices and…
